fusidic acid has been researched along with Guillain-Barre Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collidge, TA; Deighan, CJ; Mann, AC; Nolan, C; Razvi, S; Russell, AJ; Stirling, C; Whittle, M | 1 |
| Di Marco, R; Khademi, M; Muhallab, S; Nicoletti, F; Olsson, T; Wallstrom, E | 1 |
2 other study(ies) available for fusidic acid and Guillain-Barre Syndrome
| Article | Year |
|---|---|
Severe statin-induced rhabdomyolysis mimicking Guillain-Barré syndrome in four patients with diabetes mellitus treated with fusidic acid.
Topics: Aged; Anti-Bacterial Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diagnosis, Differential; Drug Interactions; Female; Fusidic Acid; Guillain-Barre Syndrome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Rhabdomyolysis; Risk Factors; Time Factors | 2010 |
Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): suppression of IFN-gamma and TNF-alpha and enhancement of IL-10.
Topics: Animals; Fusidic Acid; Guillain-Barre Syndrome; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Lymphocyte Activation; Male; Neuritis, Autoimmune, Experimental; Rats; Rats, Inbred Lew; Spleen; Transcription, Genetic; Tumor Necrosis Factor-alpha | 1999 |